Evaluation of Risk Factors for Stroke/Embolism and of Complications Due to Anticoagulant Therapy in Atrial Fibrillation
Cornelius Wehinger(Krankenanstalt Rudolfstiftung der Stadt Wien), Josef Finsterer(Seibersdorf Laboratories (Austria)), Thomas Länger(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Barbara Schneider(Altonaer Kinderkrankenhaus), Claudia Stöllberger(Seibersdorf Laboratories (Austria))
Cited by 60
Related Papers
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
|JAMA Internal Medicine|2020|1.7k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
|Cancer Cell|2018|718